Complete Filing Data
SPRUCE BIOSCIENCES, INC. reported Stockholders Equity of $42.52 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SPRUCE BIOSCIENCES, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$39.0M | -$53.0M | -$47.9M | -$46.2M | -$42.3M | -$29.5M | -$13.1M |
| Research And Development Expense | $19.5M | $46.4M | $49.4M | $35.2M | $30.7M | $23.9M | $10.8M |
| Operating Income Loss | -$36.5M | -$56.2M | -$52.0M | -$47.3M | -$42.1M | -$29.4M | -$13.1M |
| Operating Expenses | $36.5M | $61.1M | $62.1M | $47.3M | $42.1M | $29.4M | $13.1M |
| Interest Expense | $90.0K | $307.0K | $483.0K | $420.0K | $345.0K | $323.0K | $65.0K |
| General And Administrative Expense | $17.0M | $14.6M | $12.7M | $12.1M | $11.4M | $5.6M | $2.3M |
| Comprehensive Income Net Of Tax | -$53.0M | -$47.4M | -$46.6M | -$42.5M | -$29.5M | ||
| Revenues | $0.00 | $4.9M | $10.1M | $0.00 | |||
| Other Nonoperating Income Expense | $119.0K | $200.0K | $84.0K | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $558.0K | -$374.0K | -$184.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$8.2M | -$2.1M | -$14.0M | -$8.7M | -$9.2M | -$11.6M | -$12.4M | -$12.8M | -$12.8M | -$11.4M | -$11.9M | -$11.8M | -$11.4M | -$11.8M | -$9.9M | -$9.6M | -$6.4M | -$5.2M | -$2.6M | -$3.2M | -$4.1M |
| Research And Development Expense | $5.0M | -$430.0K | $10.8M | $6.6M | $8.1M | $10.3M | $13.5M | $13.1M | $11.7M | $8.8M | $9.1M | $8.5M | $8.6M | $9.1M | $6.7M | $7.8M | $5.7M | $4.6M | $2.1M | ||
| Operating Income Loss | -$8.2M | -$2.7M | -$14.5M | -$9.4M | -$10.0M | -$12.6M | -$13.7M | -$14.0M | -$13.2M | -$11.6M | -$11.9M | -$11.7M | -$11.4M | -$11.7M | -$9.8M | -$9.6M | -$6.4M | -$5.1M | -$2.6M | ||
| Operating Expenses | $8.2M | $2.7M | $14.5M | $10.0M | $11.6M | $14.6M | $16.7M | $16.1M | $15.2M | $11.6M | $11.9M | $11.7M | $11.4M | $11.7M | $9.8M | $9.6M | $6.4M | $5.1M | $2.6M | ||
| Interest Expense | $19.0K | $29.0K | $36.0K | $71.0K | $83.0K | $97.0K | $119.0K | $127.0K | $131.0K | $110.0K | $94.0K | $87.0K | $88.0K | $80.0K | $89.0K | $79.0K | $92.0K | $74.0K | $5.0K | ||
| General And Administrative Expense | $3.2M | $3.1M | $3.7M | $3.5M | $3.6M | $4.3M | $3.2M | $3.0M | $3.5M | $2.8M | $2.8M | $3.2M | $2.8M | $2.6M | $3.1M | $1.8M | $727.0K | $523.0K | $457.0K | ||
| Comprehensive Income Net Of Tax | -$8.7M | -$9.2M | -$11.6M | -$12.3M | -$12.7M | -$12.4M | -$11.4M | -$12.0M | -$12.3M | -$11.4M | -$11.8M | -$9.9M | -$9.6M | -$6.4M | |||||||
| Revenues | $0.00 | $0.00 | $0.00 | $602.0K | $1.6M | $2.0M | $3.1M | $2.2M | $2.0M | $0.00 | $0.00 | $0.00 | |||||||||
| Other Nonoperating Income Expense | $808.0K | $938.0K | $1.1M | $1.4M | $1.3M | $539.0K | $104.0K | $58.0K | $41.0K | $20.0K | $19.0K | $51.0K | $35.0K | $39.0K | $18.0K | ||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $52.0K | $133.0K | $370.0K | -$28.0K | -$152.0K | -$509.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $42.5M | $28.8M | $76.5M | $68.5M | $111.4M | $149.4M | -$30.6M | -$17.8M |
| Cash And Cash Equivalents At Carrying Value | $48.9M | $38.8M | $96.3M | $24.5M | $42.7M | $157.2M | $3.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $48.9M | $38.8M | $96.4M | $24.7M | $43.0M | $157.4M | ||
| Retained Earnings Accumulated Deficit | -$289.2M | -$250.3M | -$197.2M | -$149.3M | -$103.1M | -$60.8M | -$31.3M | |
| Other Liabilities Noncurrent | $0.00 | $282.0K | $236.0K | $161.0K | $73.0K | $118.0K | $20.0K | |
| Other Assets Noncurrent | $243.0K | $69.0K | $582.0K | $640.0K | $653.0K | $477.0K | $40.0K | |
| Long Term Debt Noncurrent | $0.00 | $124.0K | $1.7M | $3.3M | $4.9M | $1.9M | $3.2M | |
| Liabilities Current | $10.1M | $15.2M | $24.5M | $12.4M | $8.9M | $9.8M | $4.3M | |
| Liabilities And Stockholders Equity | $53.0M | $45.2M | $103.9M | $85.6M | $126.5M | $162.9M | $4.7M | |
| Liabilities | $10.5M | $16.4M | $27.4M | $17.2M | $15.1M | $13.5M | $7.5M | |
| Common Stock Value | $0.00 | $0.00 | $4.0K | $3.0K | $3.0K | $2.0K | $1.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $10.2M | -$57.6M | $71.6M | -$18.2M | -$114.4M | $153.4M | -$188.0K | |
| Assets Current | $52.1M | $44.2M | $102.2M | $83.6M | $91.9M | $160.4M | $4.7M | |
| Assets | $53.0M | $45.2M | $103.9M | $85.6M | $126.5M | $162.9M | $4.7M | |
| Additional Paid In Capital Common Stock | $331.8M | $279.1M | $273.7M | $218.4M | $214.7M | $210.3M | $664.0K | |
| Accounts Payable Current | $943.0K | $1.3M | $3.3M | $1.4M | $2.8M | $3.6M | $1.9M | |
| Restricted Cash Noncurrent | $36.0K | $35.0K | $35.0K | $29.0K | $216.0K | $216.0K | ||
| Long Term Debt Current | $0.00 | $1.6M | $1.6M | $1.6M | $0.00 | $2.6M | $1.3M | |
| Other Assets Current | $2.9M | $2.3M | $2.0M | $1.2M | $396.0K | $276.0K | $513.0K | |
| Repayments Of Long Term Debt | $2.1M | $1.6M | $1.6M | $0.00 | $4.8M | |||
| Operating Lease Liability Noncurrent | $419.0K | $736.0K | $1.0M | $1.3M | $1.3M | $1.7M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.9M | $4.1M | ||||||
| Non Cash Lease Expense | $268.0K | $247.0K | $230.0K | $355.0K | ||||
| Lease Right Of Use Asset | $666.0K | $934.0K | $1.2M | $1.4M | ||||
| Accrued Expenses And Other Current Liabilities | $9.1M | $12.3M | $14.6M | $9.4M | $6.0M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $636.0K | -$16.0K | -$121.0K | ||||
| Short Term Investments | $0.00 | $54.6M | $46.2M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | -$558.0K | -$184.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $5.4M | $13.2M | $15.3M | $51.6M | $59.2M | $66.6M | $85.4M | $96.6M | $108.0M | $78.5M | $89.1M | $100.2M | $119.7M | $130.1M | $140.7M | -$51.4M | -$42.1M | -$35.8M | -$27.5M | -$25.1M | -$21.9M | ||
| Cash And Cash Equivalents At Carrying Value | $10.7M | $16.4M | $25.6M | $60.1M | $69.7M | $81.2M | $98.8M | $97.5M | $73.9M | $21.6M | $47.2M | $23.3M | $58.4M | $78.3M | $148.6M | $72.2M | $36.6M | $41.4M | $4.8M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.7M | $16.4M | $25.7M | $60.1M | $69.7M | $81.2M | $98.8M | $97.5M | $74.0M | $21.9M | $47.4M | $23.6M | $58.6M | ||||||||||
| Retained Earnings Accumulated Deficit | -$274.6M | -$266.4M | -$264.3M | -$226.7M | -$218.0M | -$208.9M | -$187.3M | -$174.9M | -$162.1M | -$138.2M | -$126.8M | -$114.9M | -$93.9M | -$82.5M | -$70.7M | -$52.5M | |||||||
| Other Liabilities Noncurrent | $0.00 | $0.00 | $0.00 | $273.0K | $262.0K | $250.0K | $220.0K | $202.0K | $181.0K | $139.0K | $117.0K | $95.0K | $51.0K | $29.0K | $8.0K | $95.0K | |||||||
| Other Assets Noncurrent | $62.0K | $64.0K | $204.0K | $531.0K | $547.0K | $553.0K | $607.0K | $536.0K | $525.0K | $667.0K | $674.0K | $678.0K | $415.0K | $457.0K | $473.0K | $453.0K | |||||||
| Long Term Debt Noncurrent | $0.00 | $0.00 | $0.00 | $524.0K | $923.0K | $1.3M | $2.1M | $2.5M | $2.9M | $3.7M | $4.1M | $4.5M | $4.9M | $4.9M | $4.8M | $2.6M | |||||||
| Liabilities Current | $9.4M | $8.1M | $15.7M | $11.9M | $14.3M | $18.4M | $24.2M | $22.7M | $23.0M | $12.0M | $10.1M | $9.0M | $9.1M | $7.0M | $6.9M | $10.1M | |||||||
| Liabilities And Stockholders Equity | $15.3M | $21.8M | $31.6M | $65.1M | $75.5M | $87.5M | $113.0M | $126.0M | $139.1M | $95.3M | $104.5M | $115.0M | $135.1M | $143.4M | $154.0M | $78.5M | |||||||
| Liabilities | $9.9M | $8.6M | $16.3M | $13.5M | $16.4M | $20.9M | $27.6M | $29.4M | $31.1M | $16.8M | $15.4M | $14.7M | $15.4M | $13.3M | $13.3M | $14.5M | |||||||
| Common Stock Value | $0.00 | $0.00 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $1.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$13.1M | -$15.2M | $49.2M | -$19.4M | -$8.5M | $37.7M | |||||||||||||||||
| Assets Current | $14.5M | $21.0M | $30.6M | $63.6M | $73.9M | $85.9M | $111.1M | $124.1M | $137.2M | $93.2M | $96.5M | $95.1M | $93.9M | $111.4M | $151.6M | $73.6M | |||||||
| Assets | $15.3M | $21.8M | $31.6M | $65.1M | $75.5M | $87.5M | $113.0M | $126.0M | $139.1M | $95.3M | $104.5M | $115.0M | $135.1M | $143.4M | $154.0M | $78.5M | |||||||
| Additional Paid In Capital Common Stock | $280.0M | $279.6M | $279.6M | $278.3M | $277.2M | $275.5M | $272.7M | $271.5M | $270.3M | $217.5M | $216.7M | $215.8M | $213.7M | $212.6M | $211.4M | $1.1M | |||||||
| Accounts Payable Current | $1.4M | $807.0K | $1.9M | $1.8M | $682.0K | $1.9M | $3.2M | $945.0K | $3.4M | $2.2M | $1.4M | $1.1M | $2.1M | $1.1M | $2.6M | $4.0M | |||||||
| Restricted Cash Noncurrent | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $34.0K | $34.0K | $29.0K | $216.0K | $216.0K | $216.0K | $216.0K | $216.0K | $216.0K | $216.0K | |||||||
| Long Term Debt Current | $539.0K | $943.0K | $1.3M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.2M | $811.0K | $405.0K | $0.00 | $0.00 | $0.00 | $1.9M | |||||||
| Other Assets Current | $2.9M | $2.7M | $2.1M | $860.0K | $1.5M | $1.6M | $419.0K | $206.0K | $253.0K | $390.0K | $325.0K | $301.0K | $347.0K | $272.0K | $209.0K | ||||||||
| Repayments Of Long Term Debt | $405.0K | $405.0K | $405.0K | $0.00 | $4.8M | ||||||||||||||||||
| Operating Lease Liability Noncurrent | $500.0K | $580.0K | $659.0K | $950.0K | $998.0K | $1.1M | $1.2M | $1.4M | $1.5M | $1.6M | $1.7M | ||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $47.4M | $23.6M | $43.0M | $58.6M | $78.5M | $148.8M | $157.4M | $72.4M | $36.8M | $41.6M | $4.8M | ||||||||||||
| Non Cash Lease Expense | $65.0K | $60.0K | $58.0K | $82.0K | |||||||||||||||||||
| Lease Right Of Use Asset | $735.0K | $803.0K | $869.0K | $998.0K | $1.1M | $1.1M | $1.2M | $1.3M | $1.4M | ||||||||||||||
| Accrued Expenses And Other Current Liabilities | $7.5M | $6.3M | $12.4M | $12.0M | $11.6M | $12.1M | $8.7M | ||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $183.0K | -$56.0K | ||||||||||||||||||||
| Short Term Investments | $9.2M | $23.0M | $44.7M | $68.8M | $46.1M | $68.0M | $34.0M | $30.9M | |||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$3.0K | -$55.0K | -$188.0K | -$873.0K | -$845.0K | -$693.0K | -$16.0K | -$29.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $2.6M | $5.3M | $4.6M | $3.6M | $4.0M | $755.0K | $196.0K |
| Net Cash Provided By Used In Operating Activities | -$33.3M | -$56.0M | -$33.3M | -$41.7M | -$35.9M | -$27.5M | -$12.6M |
| Net Cash Provided By Used In Financing Activities | $43.5M | -$1.6M | $49.1M | -$241.0K | $643.0K | $181.0M | $12.4M |
| Increase Decrease In Other Operating Assets | $0.00 | -$494.0K | -$96.0K | -$90.0K | -$197.0K | $6.0K | $36.0K |
| Increase Decrease In Other Operating Liabilities | -$317.0K | -$237.0K | -$176.0K | -$331.0K | -$156.0K | $142.0K | $20.0K |
| Proceeds From Stock Options Exercised | $5.0K | $180.0K | $1.0K | $2.0K | $328.0K | $51.0K | |
| Net Cash Provided By Used In Investing Activities | $0.00 | $55.8M | $23.7M | -$79.2M | -$74.0K | -$4.0K | |
| Payments To Acquire Property Plant And Equipment | $0.00 | $7.0K | $8.0K | $93.0K | $74.0K | $4.0K | |
| Payments Related To Tax Withholding For Share Based Compensation | $831.0K | $246.0K | $311.0K | $40.0K | $0.00 | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.4M | -$391.0K | $2.6M | $817.0K | -$415.0K | ||
| Proceeds From Stock Plans | $25.0K | $66.0K | $169.0K | $76.0K | $134.0K | ||
| Payments To Acquire Investments | $0.00 | $11.9M | $36.8M | $79.1M | |||
| Increase Decrease In Accrued Liabilities | -$2.5M | -$2.3M | $6.3M | $3.6M | $2.3M | ||
| Increase Decrease In Accounts Payable | -$352.0K | -$2.0M | $1.9M | -$1.4M | -$805.0K | ||
| Increase Decrease In Deferred Revenue | $0.00 | -$4.9M | $4.9M | $0.00 | |||
| Proceeds From Sale Maturity And Collections Of Investments | $0.00 | $67.7M | $60.5M | $0.00 | |||
| Proceeds From Issuance Of Common Stock And Warrants | $50.0M | $0.00 | $53.6M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $544.0K | $1.6M | $1.1M | $1.1M | $1.1M | $32.0K |
| Net Cash Provided By Used In Operating Activities | -$12.7M | -$15.0M | -$11.8M | -$11.8M | -$8.8M | -$6.0M |
| Net Cash Provided By Used In Financing Activities | -$411.0K | -$227.0K | $50.5M | -$88.0K | $283.0K | $43.7M |
| Increase Decrease In Other Operating Assets | $0.00 | -$74.0K | -$157.0K | -$27.0K | -$16.0K | -$36.0K |
| Increase Decrease In Other Operating Liabilities | -$359.0K | -$55.0K | -$41.0K | -$65.0K | $23.0K | $41.0K |
| Proceeds From Stock Options Exercised | $0.00 | $180.0K | $0.00 | $2.0K | $63.0K | |
| Net Cash Provided By Used In Investing Activities | $0.00 | $10.5M | -$7.5M | -$19.0K | ||
| Payments To Acquire Property Plant And Equipment | $19.0K | |||||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $2.0K | $23.0K | $0.00 | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$492.0K | $191.0K | -$664.0K | $822.0K | ||
| Proceeds From Stock Plans | ||||||
| Payments To Acquire Investments | $0.00 | $11.9M | $11.0M | |||
| Increase Decrease In Accrued Liabilities | $140.0K | -$1.4M | -$793.0K | $1.2M | ||
| Increase Decrease In Accounts Payable | $584.0K | -$1.4M | $2.0M | -$1.7M | ||
| Increase Decrease In Deferred Revenue | $0.00 | -$2.0M | $13.0M | $0.00 | ||
| Proceeds From Sale Maturity And Collections Of Investments | $0.00 | $22.4M | $3.5M | |||
| Proceeds From Issuance Of Common Stock And Warrants | $0.00 | $53.6M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$50.83 | -$96.40 | -$1.24 | -$1.96 | -$1.81 | -$4.93 | -$17.12 |
| Common Stock Shares Outstanding | 1.4M | 563.0K | 41.0M | 23.6M | 23.5M | 23.3M | 764.4K |
| Common Stock Shares Issued | 1.4M | 563.0K | 41.0M | 23.6M | 23.5M | 23.3M | 764.4K |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 41.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 766.6K | 550.1K | 38.5M | 23.5M | 23.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 766.6K | 550.1K | 38.5M | 23.5M | 23.4M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings Per Share Basic | $-50.83 | $-96.40 | $-1.24 | $-1.96 | $-1.81 | ||
| Restricted Stock Value Shares Issued Net Of Tax Withholdings | -831.0K | -246.0K | -311.0K | -40.0K | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 23.4M | 6.0M | 764.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$14.58 | -$3.50 | -$0.32 | -$15.75 | -$16.73 | -$0.28 | -$0.30 | -$0.32 | -$0.40 | -$0.48 | -$0.51 | -$0.50 | -$0.49 | -$0.50 | -$0.42 | -$12.35 | -$8.43 | -$6.76 | -$3.34 |
| Common Stock Shares Outstanding | 563.5K | 563.0K | 42.2M | 41.3M | 41.3M | 41.2M | 40.7M | 40.7M | 39.7M | 23.6M | 23.6M | 23.5M | 23.4M | 23.4M | 23.3M | 822.0K | |||
| Common Stock Shares Issued | 563.5K | 563.0K | 42.2M | 41.3M | 41.3M | 41.2M | 40.7M | 40.7M | 39.7M | 23.6M | 23.6M | 23.5M | 23.4M | 23.4M | 23.3M | 822.0K | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 130.5M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 563.1K | 591.1K | 43.9M | 550.6K | 548.8K | 41.1M | 40.7M | 40.5M | 31.9M | 23.6M | 23.5M | 23.5M | 23.4M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 563.1K | 591.1K | 43.9M | 550.6K | 548.8K | 41.1M | 40.7M | 40.5M | 31.9M | 23.6M | 23.5M | 23.5M | 23.4M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Earnings Per Share Basic | $-14.58 | $-3.50 | $-0.32 | $-15.75 | $-16.73 | $-0.28 | $-0.30 | $-0.32 | $-0.40 | $-0.48 | $-0.51 | $-0.50 | $-0.49 | ||||||
| Restricted Stock Value Shares Issued Net Of Tax Withholdings | -11.0K | -2.0K | -71.0K | -23.0K | -40.0K | ||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 23.5M | 23.5M | 23.4M | 23.3M | 23.3M | 776.2K | 764.4K | 764.4K | 764.4K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.6M | $5.3M | $4.6M | $3.6M | $4.0M | $755.0K | $196.0K |
| Prepaid Expense Current | $353.0K | $3.2M | $3.9M | $3.3M | $2.5M | $3.0M | $215.0K |
| Stock Issued During Period Value Stock Options Exercised | $5.0K | $180.0K | $1.0K | $2.0K | $328.0K | $51.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $25.0K | $66.0K | $169.0K | $76.0K | $134.0K | ||
| Interest And Other Income | $1.1M | $3.4M | $4.6M | $1.5M | $119.0K | ||
| Depreciation And Amortization | $21.0K | $46.0K | $70.0K | $74.0K | $68.0K | ||
| Interest Paid Net | $68.0K | $225.0K | $369.0K | $266.0K | $207.0K | $192.0K | $20.0K |
| Loss On Disposal Of Property And Equipment | $0.00 | $2.0K | $2.0K | $39.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $415.0K | -$77.0K | $544.0K | $1.1M | $1.7M | $1.6M | $1.1M | $1.2M | $1.1M | $783.0K | $905.0K | $1.1M | $1.0M | $1.0M | $1.1M | $218.0K | $96.0K | $32.0K | $62.0K | $77.0K | $15.0K |
| Prepaid Expense Current | $932.0K | $1.9M | $2.9M | $2.7M | $2.7M | $3.1M | $2.7M | $3.4M | $3.4M | $2.8M | $3.4M | $1.3M | $1.8M | $2.7M | $1.2M | ||||||
| Stock Issued During Period Value Stock Options Exercised | $180.0K | $2.0K | $17.0K | $80.0K | $63.0K | $43.0K | $8.0K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $3.0K | $52.0K | $99.0K | $38.0K | $96.0K | ||||||||||||||||
| Interest And Other Income | $36.0K | $654.0K | $487.0K | $808.0K | $938.0K | $1.1M | $1.4M | $1.3M | $539.0K | $266.0K | $104.0K | $58.0K | $41.0K | ||||||||
| Depreciation And Amortization | $6.0K | $15.0K | $19.0K | $21.0K | |||||||||||||||||
| Interest Paid Net | $53.0K | $54.0K | $46.0K | ||||||||||||||||||
| Loss On Disposal Of Property And Equipment | $0.00 | $2.0K |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.